Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy

This study has been completed.
Information provided by (Responsible Party):
Amgen Identifier:
First received: May 3, 2002
Last updated: May 7, 2013
Last verified: May 2013